About Elion Therapeutics
Elion Therapeutics is a private company based in New York, New York. It has reported $25,436,790 raised in one offering on Form D since June 2024.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 11, 2024 | Jun 26, 2024 | $25,436,790of $83.8M target | 6 | $4.2M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Elion Therapeutics's Form D filed Jun 26, 2024.
JF
Jim Flynn
Director
Kieren Marr
Executive officer and director
Also a founder and president, director at Pearl Diagnostics.
MH
Martin Heidecker
Director
JL
Jonathan Leff
Director